II. Indications
- Diabetic Ketoacidosis in adults
III. Protocol: Subcutaneous InsulinLispro
- Initial dose: 0.3 units/kg
- Next: 0.1 units/kg/hour until Hyperglycemia corrects
- Next: 0.05 units/kg/hour until DKA resolves
- Coadminister fluids as per Diabetic Ketoacidosis
- Discontinue hourly dosing when Glucose 150-200
IV. Precautions
- Correct Hypokalemia prior to Insulin Dosing
- Fluid administration is central to DKA treatment
V. Monitoring
- Blood Glucose every 30 minutes to 1 hour
VI. Advantage over Insulin Infusion
- May be monitored on regular medical ward (non-ICU)
- Reduced cost by 39% compared with infusion
VII. Safety and efficacy
- As effective and safe as Insulin Infusion